Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Boston Scientific Invests In Urology With $600M Augmenix Acquisition

Sep 07 2018

• By Reed Miller

MT1809_M-A Merger — • Source: shutterstock.com

Related Content

Big Medtech’s interest in urology deepens as Boston bags AMS men’s health biz

Mar 02 2015

Augmenix Looks To Apply Hydrogel Technology Beyond Prostate Cancer

Oct 11 2017

Related Companies

Boston Scientific Corporation

Augmenix, Inc.

Endo, Inc.

Additional Topics

M & A Commercial Companies Cancer Gynecology & Urology Medical Device

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window